Ingevity Corporation
NGVT
$40.47
$0.180.45%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 284.00M | 298.80M | 376.90M | 390.60M | 340.10M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 284.00M | 298.80M | 376.90M | 390.60M | 340.10M |
| Cost of Revenue | 170.60M | 190.60M | 247.00M | 267.40M | 240.40M |
| Gross Profit | 113.40M | 108.20M | 129.90M | 123.20M | 99.70M |
| SG&A Expenses | 43.10M | 39.30M | 38.70M | 41.40M | 47.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | 500.00K |
| Total Operating Expenses | 221.40M | 237.20M | 292.40M | 316.10M | 294.90M |
| Operating Income | 62.60M | 61.60M | 84.50M | 74.50M | 45.20M |
| Income Before Tax | 26.80M | 8.80M | -137.90M | -334.60M | -71.90M |
| Income Tax Expenses | 6.30M | -7.80M | -30.70M | -50.90M | -15.90M |
| Earnings from Continuing Operations | 20.50M | 16.60M | -107.20M | -283.70M | -56.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.50M | 16.60M | -107.20M | -283.70M | -56.00M |
| EBIT | 62.60M | 61.60M | 84.50M | 74.50M | 45.20M |
| EBITDA | 85.10M | 94.30M | 103.20M | 101.80M | 74.80M |
| EPS Basic | 0.56 | 0.46 | -2.95 | -7.81 | -1.54 |
| Normalized Basic EPS | 0.69 | 0.63 | 1.07 | 0.49 | -0.06 |
| EPS Diluted | 0.56 | 0.45 | -2.95 | -7.81 | -1.54 |
| Normalized Diluted EPS | 0.69 | 0.63 | 1.07 | 0.49 | -0.06 |
| Average Basic Shares Outstanding | 36.38M | 36.30M | 36.35M | 36.34M | 36.26M |
| Average Diluted Shares Outstanding | 36.66M | 36.60M | 36.35M | 36.34M | 36.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |